NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease
- PMID: 38238500
- DOI: 10.1007/s10157-023-02442-x
NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease
Abstract
Background: Patients with end-stage kidney disease (ESKD) are at high risk of cardiovascular disease including stroke, heart failure, and ischemic heart disease (IHD). To prevent the occurrence and progression of CVD, a reliable prognostic cardiac biomarker is essential. We investigated the prognostic value of NT-proBNP for each incident type of CVD.
Methods: Male patients from the Ibaraki Dialysis Initiation Cohort (iDIC) study with preserved serum samples from dialysis initiation day (n = 212) were analyzed. Patients were classified into four groups according to quartiles of baseline NT-pro BNP levels. The relationship between NT-proBNP levels at the initiation of dialysis and the subsequent incidence of hospitalization events due to IHD, heart failure, and stroke was analyzed.
Results: The incidence rate for hospitalization due to IHD was significantly higher in the highest NT-proBNP category (Log rank p = 0.008); those of stroke and heart failure showed no significant differences among quartiles. Cox proportional hazards regression analysis revealed that serum NT-proBNT was the only prognostic factor for hospitalization for IHD after adjustment by major known IHD risk factors. (HR, 1.008; 95% confidence interval, 1.002-1.014; p = 0.01) The ROC curve analysis for the incidence of hospitalization due to IHD showed that NT-proBNP had an area under the curve (AUC) of 0.759 (95% CI 0.622-0.897; p = 0.004) at a cut-off value of 956.6 pg/mL.
Conclusion: NT-proBNP measurement at the initiation of dialysis therapy is useful to predict later hospitalization for IHD.
Trial registration: UMIN000010806.
Keywords: Dialysis; Hospitalization; Ischemic heart disease; NT-proBNP.
© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.
Similar articles
-
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28. Clin Chim Acta. 2019. PMID: 30594544
-
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27. Intern Med. 2018. PMID: 29709934 Free PMC article.
-
Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.Kidney Blood Press Res. 2014;39(6):636-47. doi: 10.1159/000368452. Epub 2014 Dec 19. Kidney Blood Press Res. 2014. PMID: 25571877
-
Heart failure biomarkers in hemodialysis patients.Cardiol J. 2024;31(4):628-636. doi: 10.5603/cj.92167. Epub 2024 Jul 12. Cardiol J. 2024. PMID: 38994825 Free PMC article. Review.
-
Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Jul 23;8:697837. doi: 10.3389/fcvm.2021.697837. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34368254 Free PMC article.
Cited by
-
N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease.Int J Mol Sci. 2024 May 23;25(11):5696. doi: 10.3390/ijms25115696. Int J Mol Sci. 2024. PMID: 38891884 Free PMC article.
-
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471. Cells. 2024. PMID: 39273041 Free PMC article. Review.
-
A retrospective multi-site examination of chronic kidney disease using longitudinal laboratory results and metadata to identify clinical and financial risk.BMC Nephrol. 2024 Dec 6;25(1):447. doi: 10.1186/s12882-024-03869-4. BMC Nephrol. 2024. PMID: 39639199 Free PMC article.
References
-
- Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:S16–23. - PubMed
-
- Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33:28–34. - DOI
-
- Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure. Eur Hear J. 2003;24:1735–43. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials